Aurdan Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.08M Sell
11,280
-219
-2% -$75K 1.04% 25
2026
Q1
$4.05M Sell
11,499
-18
-0.2% -$6.42K 1.21% 21
2025
Q4
$3.77M Sell
11,517
-68
-0.6% -$21.6K 1.16% 20
2025
Q3
$3.27M Sell
11,585
-5,316
-31% -$1.54M 1.04% 24
2025
Q2
$4.72M Sell
16,901
-4,937
-23% -$1.4M 1.61% 16
2025
Q1
$6.8M Sell
21,838
-3,437
-14% -$1.01M 2.56% 11
2024
Q4
$6.59M Buy
+25,275
New +$7.5M 2.53% 12

Other funds holding AMGN

Aurdan Capital Management's AMGN Position: Q2 2026 in Review

Aurdan Capital Management reduced its Amgen (AMGN) stake by 1.9% in Q2 2026, selling an estimated $75K and leaving 11,280 shares worth $4.08M. The position accounts for 1.04% of the portfolio, ranked #25.

Aurdan Capital Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.8M in Q1 2025. 1,292 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Aurdan Capital Management held 11,280 shares of Amgen worth $4.08M as of Q2 2026.
  • Aurdan Capital Management sold 219 Amgen shares in Q2 2026, an estimated $75K.
  • Amgen made up 1.04% of Aurdan Capital Management's portfolio in Q2 2026, its #25 holding.
  • Aurdan Capital Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Aurdan Capital Management's Amgen position peaked at $6.8M in Q1 2025.
  • 1,292 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Aurdan Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.